News Conference News ESC 2015 MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI Yael L. Maxwell September 02, 2015
News Conference News ESC 2015 PLATFORM: More Than 60% of Planned Catheterizations Cancelled When CT-Derived FFR Guides Care L.A. McKeown September 02, 2015
News Conference News ESC 2015 Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes Yael L. Maxwell September 01, 2015
News Industry News Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study September 01, 2015
News Conference News ESC 2015 DAPT Analysis Eases Concerns Over Slightly Higher Death Rate Seen With Extended Thienopyridine Use Caitlin E. Cox September 01, 2015
News Conference News ESC 2015 UK Registry: No Relationship Between Hospital PCI Volume and Early Mortality Yael L. Maxwell September 01, 2015
News Conference News ESC 2015 NSAIDs Plus Anticoagulants a Bad Combination Caitlin E. Cox September 01, 2015
News Conference News ESC 2015 Registry Provides Support for Use of MitraClip in Lower-Risk Patients L.A. McKeown September 01, 2015
News Conference News ESC 2015 Prehospital Administration of Ticagrelor Cuts Early Ischemic Events in STEMI Patients L.A. McKeown September 01, 2015
News Industry News Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure August 31, 2015